Mycobacterium leprae (Leprosy)
- 31 October 2014
- book chapter
- Published by Elsevier
- p. 2819-2831.e2
- https://doi.org/10.1016/b978-1-4557-4801-3.00252-6
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- NOD2 triggers an interleukin-32–dependent human dendritic cell program in leprosyNature Medicine, 2012
- Molecular Drug Susceptibility Testing and Genotyping of Mycobacterium leprae Strains from South AmericaAntimicrobial Agents and Chemotherapy, 2011
- Endemic Leprosy in New York CityArchives of Dermatology, 2011
- Probable Zoonotic Leprosy in the Southern United StatesNew England Journal of Medicine, 2011
- Insight toward Early Diagnosis of Leprosy through Analysis of the Developing Antibody Responses of Mycobacterium leprae -Infected ArmadillosClinical and Vaccine Immunology, 2011
- Common Polymorphisms in theNOD2Gene Region Are Associated with Leprosy and Its Reactive StatesThe Journal of Infectious Diseases, 2010
- Powerful Bactericidal Activity of Moxifloxacin in Human LeprosyAntimicrobial Agents and Chemotherapy, 2008
- Are Variable-Number Tandem Repeats Appropriate for GenotypingMycobacterium leprae?Journal of Clinical Microbiology, 2008
- Serum levels of interferon-γ, tumour necrosis factor-α, soluble interleukin-6R and soluble cell activation markers for monitoring response to treatment of leprosy reactionsClinical and Experimental Immunology, 2007
- Massive gene decay in the leprosy bacillusNature, 2001